Monterola, Niño O.

HRN: 28-99-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/12/2026
05/18/2026
IV
600mg
Q8
Fracture, Abrasions
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines